| AA | Arachidonic acid |
| Aβ | Beta-amyloid peptide |
| AβO | Aβ oligomers |
| AD | Alzheimer’s disease |
| ADAD | Autosomal-dominant Alzheimer’s disease |
| ALA | Alpha linolenic acid |
| aMCI | Amnesic mild cognitive impairment |
| APOE | Apolipoprotein E |
| APP | Amyloid precursor protein |
| BBB | Blood–brain barrier |
| BPSD | Behavioral and psychological symptoms of dementia |
| CBS | Cognitive-behavioral syndrome |
| CSF | Cerebrospinal fluid |
| CNS | Central nervous system |
| CNTF | Ciliary neurotrophic factor |
| DHA | Docosahexaenoic acid |
| ECM | Extracellular matrix |
| EPA | Eicosapentaenoic acid |
| FA | Fatty acid |
| FDG-PET | Fluorodeoxyglucose positron emission tomography |
| GFP | Green Fluorescent Protein |
| HSV-1 | Herpes simplex virus type I |
| IN | Intranasal |
| iPSC | Pluripotent stem cell |
| LA | Linoleic acid |
| LC-PUFA | Long-chain polyunsaturated fatty acid |
| Lf | Lactoferrin |
| MCI | Mild cognitive impairment |
| MOR | Opioid receptor mu |
| MRI | Magnetic resonance imaging |
| n-3 | Omega-3 |
| n-3 PUFA | Omega-3 polyunsaturated fatty acid |
| n-6 | Omega 6 |
| ND | Neurodegenerative disease |
| NFT | Neurofibrillary tangles |
| NHP | Non-human primate |
| NIA-AA | National Institute of Aging and the Alzheimer’s Association |
| NL | Nanoliposome |
| NMDA | N-methyl-D-aspartate |
| NP | Nanoparticle |
| NPC | Neural progenitor cell |
| PC | Phosphatidylcholine |
| PE | Phosphatidylethanolamine |
| PET | Positron emission tomography |
| PITRM1 | Pitrilysin metallopeptidase 1 |
| PL | Phospholipid |
| PLGA | Poly(lactic-co-glycolic acid) |
| PS | Phosphatidylserine |
| PSEN1 | Presenilin 1 |
| PSEN2 | Presenilin 2 |
| PUFA | Polyunsaturated fatty acid |
| ROS | Reactive oxygen species |
| RVG | Rabies virus glycoprotein |
| SAD | Sporadic Alzheimer Disease |
| SEM | Scanning electron microscopy |
| Tau | Tubule Associated Unit |
| Tf | Transferrin |
| TfR | Transferrin receptor |